LAMP1 and neoplasm: Our data also confirmed our conjecture that the proportion of activated CD8+ T, natural killer (high expression of IFNγ or CD107a), and Th17 cells in tumor tissues and peripheral blood of CHMACS-treated mice was markedly higher.